There are 2789 resources available
42P - Analysis of canonical uveal melanoma aberrations in murine uveal melanocytes
Presenter: Yoseph Sayegh
Session: ePoster Display
43P - Exploring the immune contexture within tumor microenvironment in non-small cell lung carcinoma (NSCLC) by multiplex immunohistochemistry
Presenter: Chih-Hung Ye
Session: ePoster Display
93P - Identifying the origin of lung-specific cancer of unknown primary based on comprehensive genomic profiling optimized with DNA methylation
Presenter: Yun Fan
Session: ePoster Display
94P - ESCAT ranking of genomic alterations collected in the Italian Registry of Actionable Mutations
Presenter: Riziero Esposito Abate
Session: ePoster Display
44P - All-trans retinoic acid modulates H19, telomerase, miR-let-7a, and glycolytic metabolism in breast cancer
Presenter: Rita El Habre
Session: ePoster Display
45P - Analysis of HER2 distribution concordance in breast cancer tissue by serial IHC staining
Presenter: Guan-Ru Peng
Session: ePoster Display
Resources:
Abstract
1362TiP - Capmatinib versus docetaxel in pretreated patients with MET exon 14 skipping-mutated locally advanced or metastatic NSCLC: The GeoMETry-III phase III study
Presenter: Pierre-Jean Souquet
Session: ePoster Display
1363TiP - A phase I/II study of TPX-0131, a novel oral ALK tyrosine kinase inhibitor, in patients with ALK+ advanced/metastatic NSCLC
Presenter: Ben Solomon
Session: ePoster Display
1364TiP - Phase II single-arm trial of safety, antitumor activity, and pharmacokinetics of tusamitamab ravtansine (SAR408701) plus ramucirumab in CEACAM5-positive, metastatic, non-squamous, non-small cell lung cancer progressing on platinum-based chemotherapy and immunotherapy
Presenter: Byoung Chul Cho
Session: ePoster Display